Home

Isaac Aktuelle Nachrichten Nicht autorisiert achim aigner leipzig Heimat unterbrechen Unterschlagen

SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted  miRNA for the Treatment of Pancreatic Cancer - SiSaf Ltd
SiSaf and the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA for the Treatment of Pancreatic Cancer - SiSaf Ltd

PDF) Targeted CRM197-PEG-PEI/siRNA complexes for therapeutic RNAi in  glioblastoma
PDF) Targeted CRM197-PEG-PEI/siRNA complexes for therapeutic RNAi in glioblastoma

Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines
Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Aktuelles
Aktuelles

Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug  Discovery World (DDW)
Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim Aigner | Leipzig University, Germany | | Conferenceseries
Achim Aigner | Leipzig University, Germany | | Conferenceseries

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie

Neuartige Gentherapie zur Behandlung des Glioblastoms
Neuartige Gentherapie zur Behandlung des Glioblastoms

Achim Aigner | Leipzig University, Germany | | Conferenceseries
Achim Aigner | Leipzig University, Germany | | Conferenceseries

Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines
Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

SiSaf and the University of Leipzig Partner to Develop
SiSaf and the University of Leipzig Partner to Develop

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Björn Simon
Björn Simon

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Pancreatic Cancer Therapy Using miRNA
Pancreatic Cancer Therapy Using miRNA

Traueranzeigen | trauer.op-online.de
Traueranzeigen | trauer.op-online.de

Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines
Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines